Page 111 - 2020年19期

参考文献 [14] ZINMAN B，ARODA VR，BUSE JB，et al. Efficacy，safe-
[ 1 ] International Diabetes Federation. The 9th edition of the dia- ty，and tolerability of oral semaglutide versus placebo
betes atlas[EB/OL].（2019-11-15）[2020-05-28]. http：// added to insulin with or without merformin in patients
www.diabetesatlas.org. with type 2 diabetes：the PIONEER 8 trial[J]. Diabetes
[ 2 ] INZUCCHI SE，BERGENSTAL RM，BUSE JB，et al. Ma- Care，2019，42（12）：2262-2271.
nagement of hyperglycemia in type 2 diabetes，2015：a pa- [15] RODBARD HW，ROSENSTOCK J，CANANI LH，et al.
tient-centered approach：update to a position statement of Oral semaglutide versus empagliflozin in patients with
the American Diabetes Association and the European As- type 2 diabetes uncontrolled on metformin：the PIONEER
sociation for the study of diabetes[J]. Diabetes Care， 2 trial[J]. Diabetes Care，2019，42（12）：2272-2281.
2015，38（1）：140-149. [16] PRATLEY R，AMOD A，HOFF ST，et al. Oral semaglu-
[ 3 ] 中华医学会糖尿病学分会.中国 2 型糖尿病防治指南： tide versus subcutaneous liraglutide and placebo in type 2
2017年版[J].中华糖尿病杂志，2018，10（1）：4-67. diabetes （PIONEER 4）：a randomised，double-blind，
[ 4 ] DUGAN JA. Standards of care and treatment in diabetes[J]. phase 3a trial[J]. Lancet，2019，394（10192）：39-50.
Phys Assist Clin，2017，2（1）：13-23. [17] ROSENSTOCK J，ALLISON D，BIRKENFELD AL，et al.
[ 5 ] GENTILELLA R，PECHTNER V，CORCOS A，et al. Glu- Effect of additional oral semaglutide vs sitagliptin on gly-
cagon-like peptide-1 receptor agonists in type 2 diabetes cated hemoglobin in adults with type 2 diabetes uncon-
treatment：are they all the same?[J]. Diabetes Metab Res trolled with metformin alone or with sulfonylurea：the
Rev，2019，35（1）：3070-3082. PIONEER 3 randomized clinical trial[J]. JAMA，2019，321
[ 6 ] LOVSHIN JA. Glucagon-like peptide-1 receptor agonists： （15）：1466-1480.
a class update for treating type 2 diabetes[J]. Can J Diabe- [18] PIEBER TR，BODE B，MERTENS A，et al. Efficacy and
tes，2017，41（5）：524-535. safety of oral semaglutide with flexible dose adjustment
[ 7 ] LU JM. The role of glucagon-like peptide-1 receptor ago- versus sitagliptin in type 2 diabetes（PIONEER 7）：a mul-
nists in type 2 diabetes in Asia[J]. Adv Ther，2019，36（4）： ticentre，open-label，randomised，phase 3a trial[J]. Lancet
798-805. Diabetes Endocrinol，2019，7（7）：528-539.
[ 8 ] ABBASI J. Oral GLP-1 analog for type 2 diabetes on the [19] ANDREADIS P，KARAGIANNIS T，MALANDRIS K，
horizon[J]. JAMA，2018，320（6）：539-556. et al. Semaglutide for type 2 diabetes mellitus：a systema-
[ 9 ] HANSEN BB，NUHOHO S，ALI AN，et al. Oral semaglu- tic review and meta-analysis[J]. Diabetes Obes Metab，
tide versus injectable glucagonlike peptide-1 receptor ago- 2018，20（9）：2255-2263.
nists：a cost of control analysis[J]. J Med Econ，2020，23 [20] 卢志伟，孙浩，李莹，等.长效GLP-1受体激动药索马鲁肽
（6）：650-658. 治疗2型糖尿病疗效和安全性的系统评价[J].中国药房，
[10] MARSO SP，BAIN SC，CONSOLI A，et al. Semaglutide 2019，30（7）：969-975.
and cardiovascular outcomes in patients with type 2 diabe- [21] BUCHEIT JD，PAMULAPATI LG，CARTER N，et al.
tes[J]. N Engl J Med，2016，375（19）：1834-1844. Oral semaglutide：a review of the first oral glucagon-like
[11] GREEN S，HIGGINS JPT，ALDERSON P，et al. Co- peptide-1 receptor agonist[J]. Diabetes Technol Ther，
chrane handbook for systematic reviews of interven- 2020，22（1）：10-18.
tions[EB/OL]. [2020-01-15]. http：//www.cochrane-hand- [22] BUCKLEY ST，BAEKDAL TA，VEGGE A，et al. Trans-
book.org. cellular stomach absorption of a derivatized glucagon-
[12] BANARES R，ALBILLOS A，RINCON D，et al. Endo- like peptide-1 receptor agonist[J]. Sci Translat Med，2018，
scopic treatment versus endoscopic plus pharmacologic 10（467）：7047-7056.
treatment for acute variceal bleeding：a meta-analysis[J]. [23] FONSECA VA，CAPEHORN MS，GARG SK，et al. Re-
Hepatology，2002，35（3）：609-615. ductions in insulin resistance are mediated primarily via
[13] ARODA VR，TERAUCHI Y，ALTUNTAS Y，et al. weight loss in subjects with type 2 diabetes on semaglu-
PIONEER 1：randomized clinical trial of the efficacy and tide[J]. J Clin Endocrinol Metab，2019，104（9）：4078-
safety of oral semaglutide monotherapy in comparison 4086.
with placebo in patients with type 2 diabetes[J]. Diabetes （收稿日期：2020-06-30 修回日期：2020-08-11）
Care，2019，42（9）：1724-1732. （编辑：刘明伟）

中国药房 2020年第31卷第19期 China Pharmacy 2020 Vol. 31 No. 19 ·2405 ·